Carlyle to acquire Unchained Labs for $435m

Carlyle to acquire Unchained Labs for $435m

Carlyle Group has agreed to buy a majority stake in life sciences company Unchained Labs for $435m, the private equity firm said on Monday. The move underscores growing private equity interest in life sciences businesses, including biopharmaceutical companies and...
U.S. Private Equity Firm Bets on Boom in U.K. Science Labs

U.S. Private Equity Firm Bets on Boom in U.K. Science Labs

Harrison Street Real Estate Capital LL is betting on the growth of the U.K.’s bio-tech industry with a deal to combine the country’s largest science incubator with a portfolio of science parks. The company has formed a venture with Trinity Investment Management to...